The interaction between programmed cell death ligand-1 (PD-L1) and programmed cell death protein-1 (PD-1) is a common and important immune-evading mechanism in many cancer types and blocking this interaction has emerged as a breakthrough in cancer therapy5. Here, PDCD1 is linked to cancer.